We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A New York judge has set a Jan. 20 trial date for opioid litigation led by the state’s attorney general against opioid manufacturers and distributors. Read More
The FDA, EMA and Japan’s Pharmaceuticals and Medical Devices Agency have made strides toward aligning clinical trial designs for antibacterial drug indications, the regulators announced following their fourth tripartite meeting in Tokyo. Read More
The Department of Health and Human Services slapped Gilead with a patent infringement suit in a federal court on Tuesday over its HIV drugs Truvada and Descovy. Read More
The indications listed for opioid products must emphasize that opioids should only be used after other analgesics have been found to be ineffective, the agency said. Read More
Makena is the only FDA approved drug for preventing preterm birth in women who are pregnant with one child and have a history of preterm births. Read More